We found that β-arrestin–biased AT1R stimulation promoted pulmonary vascular remodeling, demonstrating that vasodilation in the presence of β-arrestin-biased AT1R activation worsens PAH. The gene discussed is AGTR1; the disease is pulmonary arterial hypertension.